AP
BSX icon

Appleton Partners’s Boston Scientific BSX Stock Holding History

Appleton Partners’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,040
Closed -$219K – 257
2025
Q2 		$219K Buy
2,040
+16
+0.8% +$1.62K 0.02% 239
2025
Q1 		$204K Buy
+2,024
New +$204K 0.02% 237

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Appleton Partners's BSX Position: Q3 2025 in Review

Appleton Partners sold out of Boston Scientific (BSX) in Q3 2025, closing a stake of 2,040 shares — an estimated $219K sold.

Appleton Partners first reported a position in BSX in Q1 2025 and held it in 2 quarters. The position peaked at $219K in Q2 2025. 1,708 funds tracked by Wall St. Rank hold BSX as of Q3 2025.

  • Appleton Partners reported no remaining Boston Scientific position as of Q3 2025 after selling out during the quarter.
  • Appleton Partners sold 2,040 Boston Scientific shares in Q3 2025, an estimated $219K.
  • Appleton Partners first reported a position in Boston Scientific in Q1 2025 and held it in 2 quarters.
  • Appleton Partners's Boston Scientific position peaked at $219K in Q2 2025.
  • 1,708 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2025.

Based on Appleton Partners's 13F filing for Q3 2025, filed 5 Nov 2025.